Acadia Healthcare Company Inc (NASDAQ:ACHC) Q4 2016 Institutional Investor Sentiment Steady

July 18, 2017 - By Linda Rogers

 Acadia Healthcare Company Inc (NASDAQ:ACHC)  Q4 2016 Institutional Investor Sentiment Steady

Sentiment for Acadia Healthcare Company Inc (NASDAQ:ACHC)

Acadia Healthcare Company Inc (NASDAQ:ACHC) institutional sentiment decreased to 1.05 in 2016 Q4. Its down -0.21, from 1.26 in 2016Q3. The ratio turned negative, as 125 hedge funds increased and started new equity positions, while 119 sold and trimmed positions in Acadia Healthcare Company Inc. The hedge funds in our partner’s database now hold: 98.86 million shares, up from 91.37 million shares in 2016Q3. Also, the number of hedge funds holding Acadia Healthcare Company Inc in their top 10 equity positions decreased from 6 to 3 for a decrease of 3. Sold All: 56 Reduced: 63 Increased: 84 New Position: 41.

Acadia Healthcare Company, Inc. is a well-known provider of behavioral healthcare services, with activities in the United States and the United Kingdom. The company has market cap of $4.34 billion. The Firm focuses on acquiring and developing behavioral healthcare facilities. It has a 333.58 P/E ratio. The Firm operates through two divisions: U.S.

The stock decreased 0.45% or $0.22 during the last trading session, reaching $49.14. About shares traded. Acadia Healthcare Company Inc (NASDAQ:ACHC) has declined 23.20% since July 18, 2016 and is downtrending. It has underperformed by 39.90% the S&P500.

Analysts expect Acadia Healthcare Company Inc (NASDAQ:ACHC) to report $0.65 EPS on August, 4.They anticipate $0.08 EPS change or 10.96 % from last quarter’s $0.73 EPS. ACHC’s profit would be $57.41M giving it 18.90 P/E if the $0.65 EPS is correct. After having $0.46 EPS previously, Acadia Healthcare Company Inc’s analysts see 41.30 % EPS growth.

Pennant Capital Management Llc holds 4.13% of its portfolio in Acadia Healthcare Company Inc for 3.21 million shares. Sectoral Asset Management Inc owns 886,405 shares or 3.25% of their US portfolio. Moreover, Rock Springs Capital Management Lp has 2.56% invested in the company for 1.16 million shares. The Massachusetts-based Bain Capital Investors Llc has invested 2.21% in the stock. Consonance Capital Management Lp, a New York-based fund reported 510,666 shares.#img1#

Since January 1, 0001, it had 0 buys, and 10 sales for $163.78 million activity.

Acadia Healthcare Company Inc (NASDAQ:ACHC) Ratings Coverage

Ratings analysis reveals 86% of Acadia Healthcare’s analysts are positive. Out of 14 Wall Street analysts rating Acadia Healthcare, 12 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $4 while the high is $100. The stock’s average target of $62.54 is 27.27% above today’s ($49.14) share price. ACHC was included in 27 notes of analysts from August 6, 2015. The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) earned “Buy” rating by Mizuho on Monday, February 27. On Thursday, August 6 the stock rating was maintained by Mizuho with “Buy”. The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) has “Outperform” rating given on Thursday, September 15 by Robert W. Baird. KeyBanc Capital Markets maintained it with “Overweight” rating and $52 target in Wednesday, January 11 report. RBC Capital Markets maintained the shares of ACHC in report on Tuesday, May 30 with “Buy” rating. The firm earned “Outperform” rating on Tuesday, September 1 by Leerink Swann. The rating was maintained by Mizuho with “Buy” on Thursday, November 3. The stock has “Neutral” rating by Cantor Fitzgerald on Friday, January 27. The company was maintained on Wednesday, October 19 by UBS. RBC Capital Markets maintained the shares of ACHC in report on Wednesday, July 5 with “Buy” rating.

Another recent and important Acadia Healthcare Company Inc (NASDAQ:ACHC) news was published by Readingeagle.com which published an article titled: “Hospital for drug treatment proposed in Bern Township” on July 18, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: